Gilead’s CAR T-cell therapy recommended for use across the NHS
Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma
Read More
Tag: CAR T-cell
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
